nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—PTGS2—pancreatic cancer	0.387	1	CbGaD
Niflumic Acid—PLA2G4A—Epirubicin—pancreatic cancer	0.378	0.718	CbGbCtD
Niflumic Acid—UGT1A9—Irinotecan—pancreatic cancer	0.148	0.282	CbGbCtD
Niflumic Acid—Leflunomide—AHR—pancreatic cancer	0.00634	0.82	CrCbGaD
Niflumic Acid—CLCNKA—digestive system—pancreatic cancer	0.00225	0.266	CbGeAlD
Niflumic Acid—PLA2G1B—islet of Langerhans—pancreatic cancer	0.00148	0.175	CbGeAlD
Niflumic Acid—PLA2G1B—pancreas—pancreatic cancer	0.00104	0.123	CbGeAlD
Niflumic Acid—Floctafenine—PTGS2—pancreatic cancer	0.001	0.13	CrCbGaD
Niflumic Acid—PLA2G1B—digestive system—pancreatic cancer	0.000888	0.105	CbGeAlD
Niflumic Acid—UGT1A9—digestive system—pancreatic cancer	0.000813	0.096	CbGeAlD
Niflumic Acid—PTGS2—gall bladder—pancreatic cancer	0.000519	0.0613	CbGeAlD
Niflumic Acid—SLC16A1—digestive system—pancreatic cancer	0.000476	0.0563	CbGeAlD
Niflumic Acid—Mefenamic acid—PTGS2—pancreatic cancer	0.000391	0.0506	CrCbGaD
Niflumic Acid—PTGS2—islet of Langerhans—pancreatic cancer	0.00034	0.0402	CbGeAlD
Niflumic Acid—PTGS2—pancreas—pancreatic cancer	0.000239	0.0283	CbGeAlD
Niflumic Acid—PTGS1—digestive system—pancreatic cancer	0.000214	0.0253	CbGeAlD
Niflumic Acid—PTGS2—digestive system—pancreatic cancer	0.000204	0.0241	CbGeAlD
Niflumic Acid—SLC16A1—Metabolism—CD44—pancreatic cancer	4.51e-05	0.000639	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.48e-05	0.000635	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	4.46e-05	0.000633	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PIK3CG—pancreatic cancer	4.38e-05	0.000622	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SCT—pancreatic cancer	4.36e-05	0.000619	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HEY1—pancreatic cancer	4.36e-05	0.000619	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TNF—pancreatic cancer	4.33e-05	0.000615	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—PIK3CD—pancreatic cancer	4.32e-05	0.000614	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.32e-05	0.000613	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GCG—pancreatic cancer	4.32e-05	0.000613	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PRSS1—pancreatic cancer	4.25e-05	0.000604	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PPARG—pancreatic cancer	4.23e-05	0.0006	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCK—pancreatic cancer	4.16e-05	0.00059	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.11e-05	0.000583	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	4.09e-05	0.000581	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—TYMP—pancreatic cancer	4.06e-05	0.000576	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—STK11—pancreatic cancer	4.06e-05	0.000576	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CNR2—pancreatic cancer	4.05e-05	0.000575	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GLP1R—pancreatic cancer	4.05e-05	0.000575	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	4.05e-05	0.000575	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GLP1R—pancreatic cancer	4.02e-05	0.00057	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCKAR—pancreatic cancer	3.99e-05	0.000566	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—DPYD—pancreatic cancer	3.95e-05	0.000561	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	3.95e-05	0.00056	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.94e-05	0.000559	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	3.91e-05	0.000554	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—SRC—pancreatic cancer	3.88e-05	0.000551	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—JAG2—pancreatic cancer	3.87e-05	0.000549	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PIK3CD—pancreatic cancer	3.85e-05	0.000547	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—DTX4—pancreatic cancer	3.85e-05	0.000546	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TP53—pancreatic cancer	3.82e-05	0.000542	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MEN1—pancreatic cancer	3.81e-05	0.000541	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	3.81e-05	0.00054	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—VEGFA—pancreatic cancer	3.78e-05	0.000537	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—PIK3CB—pancreatic cancer	3.77e-05	0.000535	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—SLC2A2—pancreatic cancer	3.75e-05	0.000532	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PPP2R5B—pancreatic cancer	3.75e-05	0.000532	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—NRAS—pancreatic cancer	3.74e-05	0.00053	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.71e-05	0.000527	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ARG2—pancreatic cancer	3.69e-05	0.000524	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	3.64e-05	0.000517	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SHH—pancreatic cancer	3.64e-05	0.000516	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOTCH4—pancreatic cancer	3.61e-05	0.000513	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HEY2—pancreatic cancer	3.61e-05	0.000512	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IAPP—pancreatic cancer	3.59e-05	0.000509	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.58e-05	0.000508	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	3.53e-05	0.000501	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CD44—pancreatic cancer	3.5e-05	0.000497	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—TYMS—pancreatic cancer	3.49e-05	0.000496	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TGFB1—pancreatic cancer	3.47e-05	0.000493	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTHLH—pancreatic cancer	3.45e-05	0.000489	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTCH1—pancreatic cancer	3.45e-05	0.000489	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	3.44e-05	0.000488	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.43e-05	0.000487	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.4e-05	0.000482	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GCG—pancreatic cancer	3.36e-05	0.000477	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PIK3CB—pancreatic cancer	3.36e-05	0.000477	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.35e-05	0.000476	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HEY1—pancreatic cancer	3.34e-05	0.000474	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTGS2—pancreatic cancer	3.33e-05	0.000472	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GLP1R—pancreatic cancer	3.27e-05	0.000465	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.26e-05	0.000463	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TYMP—pancreatic cancer	3.22e-05	0.000458	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—DPYD—pancreatic cancer	3.22e-05	0.000457	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—KRAS—pancreatic cancer	3.22e-05	0.000456	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	3.16e-05	0.000449	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—STK11—pancreatic cancer	3.16e-05	0.000448	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	3.16e-05	0.000448	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SST—pancreatic cancer	3.15e-05	0.000447	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	3.1e-05	0.000439	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—JAG1—pancreatic cancer	3.08e-05	0.000438	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOTCH3—pancreatic cancer	3.07e-05	0.000436	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SLC2A2—pancreatic cancer	3.06e-05	0.000434	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.03e-05	0.000429	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—SRC—pancreatic cancer	3.02e-05	0.000429	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.97e-05	0.000421	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—JAG2—pancreatic cancer	2.96e-05	0.00042	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—PIK3CA—pancreatic cancer	2.95e-05	0.000419	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.95e-05	0.000418	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—VEGFA—pancreatic cancer	2.94e-05	0.000417	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.92e-05	0.000415	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.92e-05	0.000414	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MEN1—pancreatic cancer	2.92e-05	0.000414	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CNR1—pancreatic cancer	2.91e-05	0.000413	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—NRAS—pancreatic cancer	2.91e-05	0.000412	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CD44—pancreatic cancer	2.9e-05	0.000412	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PTEN—pancreatic cancer	2.9e-05	0.000412	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SLC2A2—pancreatic cancer	2.9e-05	0.000411	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TP53—pancreatic cancer	2.86e-05	0.000406	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.84e-05	0.000403	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—APOE—pancreatic cancer	2.84e-05	0.000403	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PIK3CG—pancreatic cancer	2.82e-05	0.000401	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.82e-05	0.0004	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GCG—pancreatic cancer	2.81e-05	0.000399	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GCG—pancreatic cancer	2.78e-05	0.000395	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SHH—pancreatic cancer	2.78e-05	0.000395	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IAPP—pancreatic cancer	2.75e-05	0.00039	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—HRAS—pancreatic cancer	2.73e-05	0.000388	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—TYMS—pancreatic cancer	2.72e-05	0.000386	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TGFB1—pancreatic cancer	2.7e-05	0.000383	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.69e-05	0.000381	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AGTR1—pancreatic cancer	2.68e-05	0.00038	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.66e-05	0.000378	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.66e-05	0.000377	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—STK11—pancreatic cancer	2.64e-05	0.000375	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HSPA1B—pancreatic cancer	2.64e-05	0.000374	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—STK11—pancreatic cancer	2.62e-05	0.000371	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GLP1R—pancreatic cancer	2.6e-05	0.000369	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.6e-05	0.000369	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PIK3CG—pancreatic cancer	2.56e-05	0.000364	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—DPYD—pancreatic cancer	2.56e-05	0.000363	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—KRAS—pancreatic cancer	2.5e-05	0.000355	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PIK3CD—pancreatic cancer	2.48e-05	0.000352	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PPARG—pancreatic cancer	2.48e-05	0.000351	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.46e-05	0.000349	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SLC2A2—pancreatic cancer	2.43e-05	0.000344	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—AKT1—pancreatic cancer	2.41e-05	0.000343	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.4e-05	0.000341	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CD44—pancreatic cancer	2.37e-05	0.000336	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—JAG1—pancreatic cancer	2.36e-05	0.000335	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.32e-05	0.000329	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.32e-05	0.000329	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SMAD4—pancreatic cancer	2.31e-05	0.000328	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—PIK3CA—pancreatic cancer	2.3e-05	0.000326	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.3e-05	0.000326	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GCG—pancreatic cancer	2.27e-05	0.000322	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HES1—pancreatic cancer	2.26e-05	0.000321	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PIK3CD—pancreatic cancer	2.25e-05	0.00032	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—TYMS—pancreatic cancer	2.25e-05	0.00032	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CD44—pancreatic cancer	2.24e-05	0.000318	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HSPA1A—pancreatic cancer	2.23e-05	0.000316	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TP53—pancreatic cancer	2.22e-05	0.000315	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—APOE—pancreatic cancer	2.21e-05	0.000314	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.19e-05	0.000311	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PIK3CB—pancreatic cancer	2.16e-05	0.000307	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—STK11—pancreatic cancer	2.13e-05	0.000303	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—HRAS—pancreatic cancer	2.13e-05	0.000302	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.11e-05	0.0003	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.09e-05	0.000297	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CXCL8—pancreatic cancer	2.08e-05	0.000295	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PIK3CA—pancreatic cancer	2.05e-05	0.000291	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2e-05	0.000284	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PIK3CG—pancreatic cancer	1.99e-05	0.000283	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TERT—pancreatic cancer	1.98e-05	0.000281	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PIK3CB—pancreatic cancer	1.97e-05	0.000279	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTGS2—pancreatic cancer	1.95e-05	0.000276	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PPARG—pancreatic cancer	1.92e-05	0.000273	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HIF1A—pancreatic cancer	1.89e-05	0.000269	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TSC2—pancreatic cancer	1.89e-05	0.000268	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CD44—pancreatic cancer	1.88e-05	0.000267	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—AKT1—pancreatic cancer	1.88e-05	0.000266	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—APOE—pancreatic cancer	1.85e-05	0.000262	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.84e-05	0.000261	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—TYMS—pancreatic cancer	1.84e-05	0.00026	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—APOE—pancreatic cancer	1.83e-05	0.00026	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—KDR—pancreatic cancer	1.81e-05	0.000257	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GCG—pancreatic cancer	1.8e-05	0.000256	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SMAD4—pancreatic cancer	1.77e-05	0.000251	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PIK3CD—pancreatic cancer	1.75e-05	0.000249	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.73e-05	0.000246	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HES1—pancreatic cancer	1.73e-05	0.000245	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NFKBIA—pancreatic cancer	1.72e-05	0.000244	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOTCH1—pancreatic cancer	1.71e-05	0.000242	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PTEN—pancreatic cancer	1.7e-05	0.000241	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—STK11—pancreatic cancer	1.69e-05	0.00024	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—AKT1—pancreatic cancer	1.67e-05	0.000237	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PIK3CG—pancreatic cancer	1.67e-05	0.000237	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—NRAS—pancreatic cancer	1.67e-05	0.000237	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PIK3CG—pancreatic cancer	1.65e-05	0.000235	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EGF—pancreatic cancer	1.65e-05	0.000234	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PPARG—pancreatic cancer	1.6e-05	0.000226	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.59e-05	0.000226	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PIK3CB—pancreatic cancer	1.53e-05	0.000217	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—EGFR—pancreatic cancer	1.52e-05	0.000216	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TERT—pancreatic cancer	1.52e-05	0.000215	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTGS2—pancreatic cancer	1.51e-05	0.000215	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOE—pancreatic cancer	1.49e-05	0.000212	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PIK3CD—pancreatic cancer	1.47e-05	0.000208	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TYMS—pancreatic cancer	1.46e-05	0.000207	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PIK3CD—pancreatic cancer	1.45e-05	0.000206	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HIF1A—pancreatic cancer	1.45e-05	0.000206	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TSC2—pancreatic cancer	1.45e-05	0.000205	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—KRAS—pancreatic cancer	1.44e-05	0.000204	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOE—pancreatic cancer	1.42e-05	0.000201	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.41e-05	0.000201	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PIK3CG—pancreatic cancer	1.35e-05	0.000191	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PTEN—pancreatic cancer	1.32e-05	0.000187	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.32e-05	0.000187	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOTCH1—pancreatic cancer	1.31e-05	0.000185	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PPARG—pancreatic cancer	1.3e-05	0.000185	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PIK3CB—pancreatic cancer	1.28e-05	0.000181	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PIK3CB—pancreatic cancer	1.27e-05	0.00018	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—EGF—pancreatic cancer	1.26e-05	0.000179	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTGS2—pancreatic cancer	1.25e-05	0.000178	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CXCL8—pancreatic cancer	1.23e-05	0.000174	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HRAS—pancreatic cancer	1.22e-05	0.000173	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PIK3CA—pancreatic cancer	1.2e-05	0.00017	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOE—pancreatic cancer	1.19e-05	0.000168	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PIK3CD—pancreatic cancer	1.18e-05	0.000168	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CASP3—pancreatic cancer	1.18e-05	0.000167	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCND1—pancreatic cancer	1.14e-05	0.000162	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CTNNB1—pancreatic cancer	1.13e-05	0.000161	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PIK3CD—pancreatic cancer	1.12e-05	0.000159	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.12e-05	0.000159	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MMP9—pancreatic cancer	1.11e-05	0.000158	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTEN—pancreatic cancer	1.1e-05	0.000157	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PTEN—pancreatic cancer	1.09e-05	0.000155	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—AKT1—pancreatic cancer	1.08e-05	0.000153	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PIK3CG—pancreatic cancer	1.07e-05	0.000152	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PIK3CB—pancreatic cancer	1.03e-05	0.000146	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PPARG—pancreatic cancer	1.03e-05	0.000146	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SRC—pancreatic cancer	1.02e-05	0.000145	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTGS2—pancreatic cancer	1.02e-05	0.000145	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—VEGFA—pancreatic cancer	9.97e-06	0.000142	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—STAT3—pancreatic cancer	9.88e-06	0.00014	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NRAS—pancreatic cancer	9.85e-06	0.00014	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—AKT1—pancreatic cancer	9.79e-06	0.000139	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PIK3CB—pancreatic cancer	9.79e-06	0.000139	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PIK3CD—pancreatic cancer	9.4e-06	0.000133	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PIK3CA—pancreatic cancer	9.32e-06	0.000132	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MYC—pancreatic cancer	9.18e-06	0.00013	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TGFB1—pancreatic cancer	9.15e-06	0.00013	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EGFR—pancreatic cancer	8.98e-06	0.000127	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PTEN—pancreatic cancer	8.92e-06	0.000127	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CTNNB1—pancreatic cancer	8.68e-06	0.000123	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—KRAS—pancreatic cancer	8.48e-06	0.00012	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PTEN—pancreatic cancer	8.46e-06	0.00012	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PIK3CB—pancreatic cancer	8.2e-06	0.000116	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SRC—pancreatic cancer	7.84e-06	0.000111	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PIK3CA—pancreatic cancer	7.79e-06	0.000111	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PIK3CA—pancreatic cancer	7.72e-06	0.00011	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—AKT1—pancreatic cancer	7.61e-06	0.000108	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—STAT3—pancreatic cancer	7.56e-06	0.000107	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NRAS—pancreatic cancer	7.54e-06	0.000107	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TP53—pancreatic cancer	7.54e-06	0.000107	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HRAS—pancreatic cancer	7.21e-06	0.000102	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PTEN—pancreatic cancer	7.08e-06	0.0001	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MYC—pancreatic cancer	7.03e-06	9.97e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TGFB1—pancreatic cancer	7.01e-06	9.95e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—EGFR—pancreatic cancer	6.87e-06	9.75e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—KRAS—pancreatic cancer	6.49e-06	9.21e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AKT1—pancreatic cancer	6.36e-06	9.03e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—AKT1—pancreatic cancer	6.31e-06	8.95e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PIK3CA—pancreatic cancer	6.29e-06	8.93e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PIK3CA—pancreatic cancer	5.97e-06	8.46e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HRAS—pancreatic cancer	5.52e-06	7.83e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AKT1—pancreatic cancer	5.14e-06	7.29e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PIK3CA—pancreatic cancer	5e-06	7.09e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—AKT1—pancreatic cancer	4.87e-06	6.91e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AKT1—pancreatic cancer	4.08e-06	5.79e-05	CbGpPWpGaD
